In terms of locoregional recurrence, risk remains low when patients are treated with RT tailored to their individual risk.

Locoregional recurrence rate of 2.9% overall with no variation across node-defined risk gr ...

The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their ...

Panelists discuss how significant gaps in current uncomplicated urinary tract infection (UTI) therapies include insufficient nonantibiotic preventive strategies, limited options for ...

Longer acne antibiotic duration increases recurrence and resistance without added benefit. Learn more about optimal treatment ...

Preterm birth is a major cause of neonatal illness and death, especially among women with a history of premature delivery.

Patients with stage I HER2-positive breast cancer treated with rastuzumab emtansine (T-DM1) had beneficial long-term outcomes with a 5-year disease-free survival rate of 97%, with the HER2DX score ...

STAFFORD, Texas, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, ...

LOUISVILLE, Ky. -- Minimally invasive ablative therapy for early kidney cancer had an increased risk of local and metastatic recurrence, which is associated with increased mortality, Swedish ...

Researchers found that recurrence occurred in 35 and 63% of women in the partner-treatment and control groups, respectively. HealthDay News — Treating male partners in addition to women with bacterial ...